Study on Antibody-Dependent Enhancement of SARS Coronavirus Infection
Author Information
Author(s): Yip Ming S, Cheung Chung Y, Li Ping H, Bruzzone Roberto, Peiris JS Malik
Primary Institution: HKU-Pasteur Research Centre, Hong Kong
Hypothesis
Can SARS-CoV use antibody-dependent enhancement mechanisms to increase its infectivity towards human immune cells?
Conclusion
SARS-CoV can enter human immune cells through an antibody-mediated pathway, raising concerns about the use of SARS-CoV vaccines in humans.
Supporting Evidence
- SARS-CoV can use antibody-mediated pathways to enter human immune cells.
- Only anti-SARS-CoV Spike serum induced a significant increase in viral genes and proteins in Raji B cells.
- The study raises concerns about the safety of SARS-CoV vaccines in humans.
Takeaway
This study found that a virus called SARS-CoV can sneak into immune cells using antibodies, which might make vaccines less safe.
Methodology
The study involved using heat-inactivated immune serum from vaccinated rodents to test infection of human immune cells with SARS-CoV.
Limitations
The study could not directly assess productive replication due to the low percentage of infected cells.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website